Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AFFiRiS Logo
AFFiRiS Growth Score
1
CB Rank
136800
Heat Score
35
AFFiRiS develops tailor-made peptide vaccines for alzheimer's, parkinson's, atheroclerosis, hypertension and several other conditions.
Founded
obfuscation
PrivateVenture - Series Unknown Gerasdorf Bei Wien, Niederosterreich, Austria11-50 www.affiris.com
Biotechnology
Medical
Pharmaceutical
Overview

AFFiRiS
Total Funding
obfuscation
Growth Score
1
Heat Score
35

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score1
-2 pts
in past quarter
Heat Score 35
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AFFiRiS

CB Rank
136800
AFFiRiS develops tailor-made peptide vaccines for alzheimer's, parkinson's, atheroclerosis, hypertension and several other conditions.
Founded
obfuscation
PrivateVenture - Series Unknown Gerasdorf Bei Wien, Niederosterreich, Austria11-50 www.affiris.com
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name AFFiRiS AG
Operating Status Active
Company Type For Profit
Founders  Frank Mattner, Walter Schmidt
About the Company
AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Phone Number 43 1 7981575 300
Contact Email office@affiris.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Specific Active Immunotherapy (SAIT)
A treatment that stimulates the immune system to produce antibodies targeting proteins involved in chronic diseases, aiming to inhibit disease progression.
AFFITOME Technology
A proprietary technology that designs modified peptide sequences mimicking disease-related protein epitopes to stimulate targeted immune responses.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
1
obfuscation
— Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
MIG Capital Logo
MIG Capital
—
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
—
MIG Capital Logo
MIG Capital
—
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
—
MIG Capital Logo
MIG Capital
—
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
—
MIG Capital Logo
MIG Capital
—
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
—
MIG Capital Logo
MIG Capital
—
Venture Round - AFFiRiS Logo
Venture Round - AFFiRiS
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3

Employee Profiles

News

News and Press

News•Feb 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 18, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 7, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 21, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

390
-13.72%
 in past month

IT Spend

$853KThis year, AFFiRiS is projected to spend $853K on IT, according to Aberdeen.

Actively Used Products

13AFFiRiS uses 13 technology products and services including HTML5, Lightbox, and  Comodo PositiveSSL Certificates, according to G2 Stack.

Active Website Tech Count

8AFFiRiS is actively using 8 technologies for its website, according to BuiltWith. These include HSTS, Euro, and  LetsEncrypt.

Total IP

40The intellectual property of AFFiRiS includes 39 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, AFFiRiS has 1 registered trademark in the 'Chemical substances' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AFFiRiS's headquarters? AFFiRiS is located in Gerasdorf Bei Wien, Niederosterreich, Austria.Who invested in AFFiRiS? AFFiRiS has 4 investors including MIG Capital and  Santo Holding.When was the last funding round for AFFiRiS? AFFiRiS closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are AFFiRiS's competitors? Alternatives and possible competitors to AFFiRiS may include Entrada Therapeutics, Annovis Bio, and  Flashpoint Therapeutics.How much funding has AFFiRiS raised to date? AFFiRiS has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d46e5f 1)
|